| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1829 | 2020 |
| Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study PK Bendapudi, S Hurwitz, A Fry, MB Marques, SW Waldo, A Li, L Sun, ... The Lancet Haematology 4 (4), e157-e164, 2017 | 436 | 2017 |
| Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis A Li, DA Garcia, GH Lyman, M Carrier Thrombosis research 173, 158-163, 2019 | 297 | 2019 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 287 | 2021 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Mortality in hospitalized patients with cancer and coronavirus disease 2019: a systematic review and meta‐analysis of cohort studies A Desai, R Gupta, S Advani, L Ouellette, NM Kuderer, GH Lyman, A Li Cancer 127 (9), 1459-1468, 2021 | 125 | 2021 |
| Derivation and validation of a risk assessment model for immunomodulatory drug–associated thrombosis among patients with multiple myeloma A Li, Q Wu, S Luo, GS Warnick, NA Zakai, EN Libby, BF Gage, DA Garcia, ... Journal of the National Comprehensive Cancer Network 17 (7), 840-847, 2019 | 124 | 2019 |
| External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment A Li, PR Khalighi, Q Wu, DA Garcia Journal of Thrombosis and Haemostasis 16 (1), 164-169, 2018 | 115 | 2018 |
| Safety of allogeneic hematopoietic cell transplant in adults after CD19-targeted CAR T-cell therapy M Shadman, J Gauthier, KA Hay, JM Voutsinas, F Milano, A Li, ... Blood advances 3 (20), 3062-3069, 2019 | 88 | 2019 |
| Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative PK Bendapudi, A Li, A Hamdan, L Uhl, R Kaufman, C Stowell, W Dzik, ... British journal of haematology 171 (5), 836-844, 2015 | 82 | 2015 |
| Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, MA Bilen, V Santos, J Esther, ... Cancer 126 (6), 1208-1216, 2020 | 76 | 2020 |
| Incidence, risk factors for and outcomes of transplant‐associated thrombotic microangiopathy N Epperla, A Li, B Logan, C Fretham, S Chhabra, M Aljurf, L Chee, ... British journal of haematology 189 (6), 1171-1181, 2020 | 75 | 2020 |
| Association of body weight with efficacy and safety outcomes in phase III randomized controlled trials of direct oral anticoagulants: a systematic review and meta‐analysis K Boonyawat, F Caron, A Li, C Chai‐Adisaksopha, W Lim, A Iorio, ... Journal of Thrombosis and Haemostasis 15 (7), 1322-1333, 2017 | 75 | 2017 |
| Managing thrombosis in cancer patients TF Wang, A Li, D Garcia Research and Practice in Thrombosis and Haemostasis 2 (3), 429-438, 2018 | 63 | 2018 |
| Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: a systematic review and meta‐analysis A Li, NM Kuderer, DA Garcia, AA Khorana, PS Wells, M Carrier, ... Journal of Thrombosis and Haemostasis 17 (12), 2141-2151, 2019 | 58 | 2019 |
| Transplant-associated thrombotic microangiopathy is a multifactorial disease unresponsive to immunosuppressant withdrawal A Li, Q Wu, C Davis, KS Kirtane, PD Pham, ML Sorror, SJ Lee, AK Gopal, ... Biology of Blood and Marrow Transplantation 25 (3), 570-576, 2019 | 55 | 2019 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| A new prognostic model in patients with advanced urothelial carcinoma treated with first-line immune checkpoint inhibitors AR Khaki, A Li, LN Diamantopoulos, NJ Miller, L Carril-Ajuria, ... European urology oncology 4 (3), 464-472, 2021 | 45 | 2021 |
| Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura L Sun, J Mack, A Li, J Ryu, VA Upadhyay, L Uhl, RM Kaufman, CP Stowell, ... Blood advances 3 (9), 1512-1518, 2019 | 45 | 2019 |
| Association between androgen deprivation therapy and mortality among patients with prostate cancer and COVID-19 AL Schmidt, MD Tucker, Z Bakouny, C Labaki, CY Hsu, Y Shyr, ... JAMA network open 4 (11), e2134330-e2134330, 2021 | 39 | 2021 |
